Q32 Bio Inc.
QTTB
$15.15
-$0.22-1.43%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -8.95M | -7.61M | 57.73M | -7.39M | -9.49M |
| Total Depreciation and Amortization | 85.00K | 90.00K | 90.00K | 91.00K | 91.00K |
| Total Amortization of Deferred Charges | -33.00K | 33.00K | 37.00K | 46.00K | -48.00K |
| Total Other Non-Cash Items | 1.97M | 1.71M | -63.85M | 1.33M | 2.11M |
| Change in Net Operating Assets | 3.85M | -568.00K | -190.00K | 1.69M | -3.31M |
| Cash from Operations | -3.08M | -6.34M | -6.18M | -4.23M | -10.65M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | 7.00M | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 7.00M | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -8.26M | -1.56M | -1.56M | -1.56M | -- |
| Issuance of Common Stock | 66.85M | 10.36M | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 58.59M | 8.80M | -1.56M | -1.56M | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 55.52M | 2.45M | -742.00K | -5.79M | -10.65M |